# Metformin in Safety and Efficacy in Gouty Patients

> **NCT06924658** · PHASE2 · RECRUITING · sponsor: **Mostafa Bahaa** · enrollment: 70 (estimated)

## Conditions studied

- Gout

## Interventions

- **OTHER:** placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06924658
- **Lead sponsor:** Mostafa Bahaa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2026-11-20
- **Final completion:** 2026-11-20
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06924658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06924658, "Metformin in Safety and Efficacy in Gouty Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06924658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*